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T Cells Specific to Leishmania and Other Nonrelated
Microbial Antigens Can Migrate to Human
Leishmaniasis Skin Lesions
Alda M. Da-Cruz1, Manoel P. Oliveira-Neto2, A´lvaro L. Bertho3, Carolina O. Mendes-Aguiar1
and Sergio G. Coutinho4
Immunopathological studies have contributed to the characterization of in situ inflammatory infiltrates in
cutaneous leishmaniasis (CL). However, little is known about the T-cell antigen reactivity of these lesions. Our
objective was to analyze the responsiveness of lymphocytes from CL lesions to leishmanial and nonrelated
antigens in terms of proliferation and the production of cytokines. Mononuclear cells were extracted from
lesions, and blood from CL patients infected with Leishmania (Viannia) braziliensis. Activated cells accounted
for 35–45% of lesions T-cell subsets. Elevated levels of C1.7/CD244þCD8þ T cells suggest in situ cytotoxic
effector function. Lymphocytes isolated from the leishmaniasis lesions proliferated and produced IFN-g in
response to leishmanial antigens as well as to irrelevant antigens such as Toxoplasma gondii (Tg). Patients
presenting with larger lesions had the highest lymphocyte proliferation indexes. A high frequency of Tg-specific
cells was detected in the lesions by limiting dilution assay, similar to the frequency of Leishmania-specific cells.
Importantly, Tg-reactive cells were not found in lesions of patients without a history of toxoplasmosis. The
proportion of Leishmania-reactive CD4þ and CD8þ T cells in the lesions was quite variable. Overall, these data
suggest that T cells reactive to nonrelevant antigens can migrate to leishmanial lesions and possibly influence
the pathogenesis of the disease.
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INTRODUCTION
Cutaneous leishmaniasis (CL) is the most common clinical
form of American tegumentary leishmaniasis; in Brazil, it
is caused mainly by Leishmania (Viannia) braziliensis (Lb)
(Oliveira-Neto et al., 2000). CL lesions have the following
pathological characteristics: (i) a transitory, but reversible,
cellular pattern that can be modified according to disease
progression (Magalha˜es et al., 1986); (ii) distinct histopatho-
logical findings in the same lesion (Bittencourt and Barral
1991); and (iii) a granulomatous organization involving both
the synthesis and the degradation of the extracellular matrix
(Esterre et al., 1991). In contrast to other skin diseases such as
leprosy (Sarno et al., 1984; Modlin et al., 1985) and psoriasis
(Nikaein et al., 1991), the histopathological pattern has no
correlation with the clinical phase and does not predict the
outcome of the infection (Magalha˜es et al., 1986; Bittencourt
and Barral, 1991). T lymphocytes are the predominant cells
in the lesions, but the distribution of CD4þ and CD8þ T-cell
subsets is extremely variable (Barral et al., 1987; Pirmez
et al., 1990; Lima et al., 1994; Palma and Saravia, 1997;
Amato et al., 2003; Da-Cruz et al., 2005; Campanelli et al.,
2006) and does not correlate with the proportion of
Leishmania-specific T cells in blood (Tapia et al., 1994;
Da-Cruz et al., 2005). These data suggest that the local skin
microenvironment and immunoregulatory factors can favor
the recruitment, proliferation, or even death of specific T-cell
populations within the lesions (Tapia et al., 1994; Santamaria
Babi et al., 1995; Butcher and Picker, 1996; Orteu et al.,
1998; Bertho et al., 2000; Eidsmo et al., 2005).
In situ immunopathological studies have improved our
understanding of the microanatomical distribution of skin-
infiltrating cells (Barral et al., 1987; Pirmez et al., 1990; Lima
et al., 1994; Palma and Saravia, 1997), as well as the pattern
of cytokines and chemokines that are produced in American
tegumentary leishmaniasis lesions (Pirmez et al., 1993; Ritter
et al., 1996). However, given the difficulty in obtaining a
sufficient number of cells for ex vivo analysis, very few
studies have examined the antigen reactivity of the T cells
present in the lesions and how parasites infecting tissues can
modulate the local immune response. Leishmania-specific
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T-cell clones generated from lesions proliferate in response to
Leishmania, but not in response to other nonrelated antigens,
such as purified protein derivative (Pirmez et al., 1993).
Moreover, the fact that Lb-specific T cells are present at a
higher frequency in lesions than in blood clearly shows that
fundamental immunological events are occurring at this site
(Conceic¸a˜o-Silva et al., 1990).
In experimental leishmaniasis, parasite-specific T cells can
contribute to tissue damage (Titus et al., 1984). However,
although nonspecific cells have been shown to be involved in
the pathogenesis of several immune-based inflammatory
diseases (Gijbels et al., 1994; Sitia et al., 2004), this possibility
has not been examined in parasitic diseases. Our study was
based on the observation that, despite the high frequency
of Leishmania-reactive T cells in the lesions (Conceic¸a˜o-Silva
et al., 1990), they probably do not constitute the total
population of memory lymphocytes found in the affected
tissues. To address the immunoresponsiveness of the cells
infiltrating skin lesions, we evaluated T-cell activation and the
production of cytokines in response to leishmanial antigens in
American tegumentary leishmaniasis lesions. Moreover, we
investigated the possibility that lymphocytes reactive to
nonrelated antigens are also found in leishmanial lesions.
RESULTS
Responsiveness of lesion-derived T lymphocytes to leishmanial
antigens
Primary in vitro cell cultures were grown to determine the
level of cell activation based on the lymphocyte proliferative
response (LPR) and IFN-g production (Tables 1 and 2). The
LPR to Leishmania antigens was positive (stimulation index
42.5) in lesions from 12 of 23 patients, and IFN-g was
detected in 12 of 18 cases. Seventeen patients were studied
using both assays. Of these 17 patients, 14 (82.4%) had
activated lymphocytes in the lesions (9 had a positive LPR
and produced IFN-g, 3 showed only a positive LPR, and 2
produced only IFN-g); only 3 (17.6%) were not responsive in
either test. Importantly, the mononuclear cells from leishma-
nial lesions (LMNCs) of all these patients were activated
under mitogenic stimuli (Table 2). There was no correlation
between the LPR or IFN-g production and the lesion size
or induration in a Montenegro skin test, a delayed-type
hypersensitivity-based test against leishmanial antigens.
However, patients with lesions larger than 20mm (patients
17, 41, and 42) tended to show the highest levels of
lymphocyte proliferation; this increase was statistically
significant compared with those presenting with lesions
smaller than 20mm (P¼0.05; Table 1). There was no
association between the T-cell phenotype and the magnitude
of leishmanial antigen-induced lymphocyte proliferation. In
the absence of exogenous stimuli, LMNC cultures, like the
control peripheral blood mononuclear cell (PBMC) cultures,
did not proliferate. In addition, only two samples showed a
low level of IFN-g production in nonstimulated LMNC
cultures (Table 2). Thus, the T cells that had infiltrated
the lesions were able to properly respond to leishmanial
antigens, although in a minority of cases no response was
observed.
T cells derived from lesions are activated by Toxoplasma
antigens
To determine whether T lymphocytes specific for antigens not
related to Leishmania infection were present in leishmaniasis
lesions, we stimulated LMNCs with Toxoplasma gondii (Tg),
a parasite that is not phylogenetically related to Leishmania,
and Trypanosoma cruzi, which is known to have cross-
immunity with leishmanial antigens (Carvalho et al., 1987).
Sixteen leishmaniasis patients with serological evidence of
previous Toxoplasma infection were evaluated along with
seven seronegative patients (Table 3). In 12 of 16 (75%)
chronic toxoplasmosis patients, lymphocytes from the leish-
maniasis lesions were activated in response to Toxoplasma
antigens, as shown by positive LPR and/or IFN-g production.
PBMCs from all Tg-infected Lb patients studied were positive
in these tests (Table 3). A high level of IFN-g was detected in
the LMNC cultures, indicating that these lymphocytes were
able to secrete cytokines ex vivo in response to non-
leishmanial stimuli. Importantly, LMNCs and PBMCs from
leishmaniasis patients without evidence of chronic toxoplas-
mosis did not show significant lymphocyte proliferation or
IFN-g production in response to Toxoplasma antigens
(Table 3). These data show that circulating lymphocytes can
be recruited to inflamed lesions independent of their
specificity to leishmanial antigens.
As expected, blood lymphocytes responded to T. cruzi
(data not shown), but, curiously, lymphocyte reactivity
to these antigens was detected in only 2 (IE¼ 11.3 and 3.4,
IFN-g¼ 150 and 1,190 pgml1, respectively) of 18 lesions.
To ensure that there was no cross-reactivity between the
parasite antigens, we expanded short-term cultures of T
lymphocytes in vitro in the presence of Leishmania or
Toxoplasma antigens and restimulated with the parasite
antigens. T cells responding to Leishmania proliferated in
response to leishmanial antigens but not to Tg antigens (data
not shown).
To exclude the possibility that the responding lymphocytes
present in the LMNCs were a consequence of blood
extravasation during the biopsy procedure, we compared
the frequency of cells responsive to Leishmania and
Toxoplasma antigens in blood with that of lesions from three
patients also chronically infected by Tg using a limiting
dilution assay (Figure 1). As expected, a low frequency of
Leishmania-specific T cells was observed in the blood, in
contrast to the higher frequency detected in the lesions.
Interestingly, a similar profile was observed for Toxoplasma-
reactive T cells. Because the frequency of Toxoplasma-
specific T lymphocytes was greater in the lesions than in the
PBMCs (Figure 1), we can exclude the possibility of blood
contamination. Therefore, T lymphocytes reactive to non-
related antigens not only are attracted to leishmaniasis lesions
but are found in frequencies as high as those observed for
Leishmania-reactive T cells.
Type 2 cytokine production by cells from leishmaniasis lesions
Because type 2 cytokines are expressed in leishmaniasis
lesions (Pirmez et al., 1993), we investigated whether
leishmanial antigens could induce LMNCs to secrete IL-4
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and IL-5. No IL-4 was detected by ELISA in either the
stimulated PBMCs or the LMNCs. IL-5 was detected in
the cultures of PBMCs from four patients (9.9–41.1 pgml1),
but this cytokine was not detected in LMNC cultures. These
data indicate that very low levels of IL-5 are secreted by
lesion-derived cells. It is possible that similar effects occur
with IL-4, although we cannot certify this on the basis of
our current data.
Phenotypic analysis of T lymphocytes derived from
leishmaniasis lesions
Because the cellular infiltrate of lesions seemed to include
subsets of lymphocytes that recognized different antigens, we
investigated the proportion of CD4þ or CD8þ T cells directly
ex vivo (Table 1) and following expansion with leishmanial
stimuli (Figure 2).
The mean fraction of activated T cells expressing CD25
or CD69 (Figure 3) among the CD4þ T cells (CD25þ ¼
44.7±20.5%, median¼ 39.4%; CD69þ ¼59.4±18.4%,
median¼54.8%; n¼ 7) and the CD8þ T cells (CD25þ ¼
35.8±19.3%, median¼ 35.7%; CD69þ ¼36.3±12.9%,
median¼38.6%; n¼ 7) was higher in lesions than in blood
(Po0.05). Furthermore, a high proportion of CD8þ T cells
expressed C1.7 (79.3±10.5%; median¼78.9%; n¼ 7), a
molecule associated with cytotoxicity.
The percentage of Leishmania-reactive CD4þ or CD8þ
T cells isolated from the lesions was quite variable after
antigenic stimulation. The cultures from five patients con-
tained a higher percentage of Leishmania-reactive CD4þ
T cells than CD8þ T cells; cultures from four patients had a
predominance of CD8þ T cells, and cultures from four other
patients showed similar proportions of both T-cell subsets.
A similarity between the proportion of nonstimulated CD4þ
and CD8þ T lymphocytes and Leishmania-responsive T-cell
subsets in skin lesions was seen in 6 of 13 patients. However,
there was no significant association between the proportion
Table 1. Phenotypic profile of lesion-derived T lymphocytes and immune responsiveness of cells obtained from
cutaneous leishmaniasis lesions to leishmanial antigens
Patient Lesion size
Number of
cells obtained from MST
Phenotype of
lesion T lymphocytes ex vivo
Lymphoproliferative
response to Lb
IFN-c
production
number (cm2) lesion (mm) CD3+(%) CD4+(%) CD8+(%) c.p.m. SI (pgml1)
Pt 07 5.9 5106 12 37.1 31.6 16.1 210 5.3 2,520
Pt 09 3.4 5106 10 78.6 35.7 27.6 26,070 8.4 11,300
Pt 12 11.8 4.5106 15 ND 35.2 25.4 3,820 7.1 3,140
Pt 13 6.3 0.7106 08 ND 17.6 25.3 394 1.7 ND
Pt 15 4.9 3106 50 ND 19.9 46.2 850 0.4 3,890
Pt 17 29.8 12 106 20 ND 42.3 37.8 8,520 22.3 1,320
Pt 19 3.9 1.5106 02 ND 23.4 60.1 450 0.9 ND
Pt 20 5.9 2.5106 14 ND 26.4 54.8 2,720 5.1 3,480
Pt 21 4.5 5.0106 12 55.0 29.7 27.0 1,060 1.7 ND
Pt 25 7.7 9.0106 10 72.5 37.9 26.3 ND ND ND
Pt 39 2.4 3.5106 46 65.4 40.6 31.1 250 0.7 0
Pt 41 25.5 2.0106 22 ND 31.8 19.2 7,680 28.8 1,760
Pt 42 28.3 13 106 55 87.3 30.5 49.4 2,500 11.6 4,380
Pt 43 61.2 1.5106 20 54.9 28.5 19.0 2,500 3.0 0
Pt 44 5.9 2.2106 15 66.0 7.0 23.0 4,020 22.4 3,570
Pt 45 7.9 1.0106 11 32.8 9.2 24.8 316 1.6 ND
Pt 46 15.7 3.7106 26 ND 47.2 28.6 2,180 3.0 0
Pt 47 3.4 1.7106 36 ND 12.1 27.8 198 1.2 0
Pt 48 11 5.1106 22 ND 15.4 21.8 2,030 4.0 792
Pt 50 9.8 1.7106 32 ND ND ND 1,810 2.3 632
Pt 51 16.5 8.1106 13 ND ND ND 524 1.0 374
Pt 53 18.8 3.9106 16 ND ND ND 178 1.3 0
Pt 55 12.9 2.3106 39 ND ND ND 511 4.2 ND
Pt 56 5.9 0.5106 23 ND ND ND 147 1.1 0
Abbreviations: c.p.m., counts per minute; Lb, Leishmania (Viannia) braziliensis; MST, Montenegro skin test; ND, not determined; Pt, patient; SI, stimulation
index.
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of lesion-derived, Lb-reactive CD4þ and CD8þ T lymphocytes
in culture (Figure 2a) and their proportion in the inflammatory
infiltrate (Figure 2b).
DISCUSSION
Clones of lesion-derived T cells grown in IL-2-supplemented
culture medium have been used for immunological studies of
leishmaniasis (Pirmez et al., 1990) and other inflammatory
diseases, such as psoriasis (Menssen et al., 1995), leprosy
(Modlin et al., 1986), Chagas disease (Cunha-Neto et al.,
1998), and tuberculosis (Tan et al., 1997). However, the
addition of cytokines to the medium can modify the
population of T-cell subsets (Tan et al., 1997) and also
interfere with the cytokine network (Jung et al., 1995). In this
study, lesion-derived lymphocytes were able to proliferate
and/or produce IFN-g in primary ex vivo cell cultures
stimulated with Lb antigens. Although patients with larger
lesions tended to show higher levels of lymphocyte prolifera-
tion, no other clinical parameter was associated with the
immunological data. Only a small number of patients
(17.6%) did not respond to the antigens, probably because
of an advanced stage of differentiation of their lesion skin
cells. IL-4 and IL-5 were not detected in the supernatants of
cell cultures derived from any lesion, but mRNA or in situ
detection of these cytokines has already been demonstrated
(Pirmez et al., 1993; Diaz et al., 2002).
The proportion of lesion Leishmania-reactive CD4þ and
CD8þ T lymphocytes could not be consistently associated
with the T-cell subsets infiltrating these skin lesions. An
equivalent blood CD4þ /CD8þ ratio seems beneficial, given
that these ratios are most frequently observed during the
healing process (Da-Cruz et al., 1994). Although the
proportion of T cells from the lesions was variable after
expansion with leishmanial antigens, the majority of cases
presented the same profiles that could favor CD8þ T-cell
function. Accordingly, cytotoxic CD8þ T cells and NK cells
Table 2. Lymphocyte proliferative responses and IFN-c production of LMNCs or PBMCs from cutaneous
leishmaniasis patients after in vitro stimulation with Leishmania antigens or mitogen concanavalin A
LMNC1,2 PBMC1,2
In vitro T-cell stimulation LPR (c.p.m.) IFN-c (pgml1) LPR (c.p.m.) IFN-c (pgml1)
Control 553±144 (–/23) 409±215 (2/11) 610±220 (–/22) 0 (–/12)
Concanavalin A 6,600±1,510 (21/23) 4,360±1,260 (11/11) 9,820±2,520 (22/22) 2,920±590 (10/10)
Leishmania antigens 5,230±2,028 (12/23) 3,100±844 (12/18) 8,420±1,540 (22/22) 4,610±1,390 (15/15)
Abbreviations: c.p.m., counts per minute; –, no cases; LMNC, mononuclear cell derived from lesion; LPR, lymphocyte proliferative responses; PBMC,
peripheral blood mononuclear cell.
1Values are presented as the mean±standard deviation.
2In parenthesis, number of patients with positive results (LPR X2.5 or IFN-g X62.5 pgml1)/number of patients analyzed.
Table 3. Lymphocyte proliferative responses and IFN-c production of LMNCs and PBMCs from cutaneous
leishmaniasis patients after in vitro stimulation with Toxoplasma gondii antigens
LMNC2,3 PBMC2,3
Indirect immunofluorescent assays to Toxoplasma gondii1 LPR (c.p.m.) IFN-c (pgml1) LPR (c.p.m.) IFN-c (pgml1)
Seropositive 8,360±5,010 (10/16) 3,350±1,370 (5/11) 9,240±4,840 (15/15) 6,070±2,120 (11/11)
Seronegative 300±52 (7/7) 0 (2/2) 1,290±572 (7/7) 0 (2/2)
Abbreviations: c.p.m., counts per minute; –, no cases; LMNC, mononuclear cell derived from lesion; LPR, lymphocyte proliferative responses; PBMC, peripheral
blood mononuclear cell.
1The leishmaniasis patients were grouped according to the presence (seropositives) or absence (seronegatives) of serum antibodies against Toxoplasma gondii.
2Values are presented as mean±standard deviation.
3In parenthesis, number of patients with positive results (LPR X2.5 or IFN-g X62.5pgml1)/number of patients analyzed.
1 10 100 1,000 10,000
Frequency of responder lymphocytes per 106 cells
PBMC LesionLe
is
hm
an
ia
st
im
ul
i
To
xo
pl
as
m
a
st
im
ul
i
PT 53
PT 55
PT 56
PT 53
PT 55
PT 56
ND
Figure 1. Mononuclear cell from leishmanial lesion (LMNC) and PBMC
proliferation in response to parasite antigens. The frequency of cells specific
for Leishmania braziliensis or Toxoplasma gondii (Tg) antigens was
determined using limiting dilution assays as described in Materials and
Methods. The results are from three leishmaniasis patients who were also
chronically infected by Tg and are expressed as the number of parasite-
specific cells per 106 mononuclear cells. ND, not determined; PT, patient.
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were observed in situ in the dermal infiltrate of Lb patients
(Machado et al., 2002; Faria et al., 2005). However, the
presence of these effector cells, which was also suggested by
the high level of CD8þ T cells expressing C1.7 observed in
this study, does not guarantee clearance of the infection. The
observation that CD4þCD25þTreg cells derived from CL
lesions are able to suppress the proliferation of allogeneic
PBMCs suggests that these regulatory cells could impair
effector T-cell function, possibly contributing to parasite
persistence and the chronic nature of the lesions (Campanelli
et al., 2006). Therefore, the functional analysis of these
Leishmania antigen-expanded T cells should help to clarify
the balance of immune mechanisms contributing to clear-
ance of the infection.
The observation that the frequency of Leishmania-reactive
T cells is higher in lesions than in blood reinforces the idea
that an enrichment of lymphocytes occurs at the inflamma-
tory site (Conceic¸a˜o-Silva et al., 1990). It is therefore
conceivable that parasites present in the lesions can lead to
the local expansion of T cells and to the release of soluble
factors contributing to the maintenance of inflammatory
infiltrate. Local regulatory phenomena occurring at the lesion
possibly redirect the immune response of lymphocytes that
migrate from the blood. Given that memory T cells are the
predominant, but not exclusive, type of lymphocyte in lesions
(Pirmez et al., 1993), it is possible that lymphocytes with
other specificities are present in the inflammatory infiltrate.
We showed that Toxoplasma-specific T cells are present in
leishmaniasis lesions at an elevated frequency, even as high
as the frequency of Leishmania-reactive lymphocytes. More-
over, these nonspecific cells not only proliferate but also
produce cytokines such as IFN-g after stimulation with
Toxoplasma-derived antigens. Indeed, these nonspecific cells
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Figure 2. Phenotype of lesion-derived CD4þ and CD8þ T cells directly ex vivo and after stimulation with leishmanial antigens. Comparison of the proportions
of Leishmania-specific CD4þ and CD8þ T-cell mononuclear cells from leishmanial lesions (LMNCs) from 13 cutaneous leishmaniasis patients after in vitro
stimulation with Leishmania braziliensis antigens (a) and directly ex vivo (b). The boxes highlight the cases presenting similar T-cell subset profiles. Pt, patient.
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Figure 3. Activation phenotype of lesion- and blood-derived CD4þ and
CD8þ T cells directly ex vivo. Comparison of the proportions of CD4þ and
CD8þ T-cell presenting molecules associated with activation status (CD25
and CD69) measured directly ex vivo in mononuclear cells from lesions and
blood of cutaneous leishmaniasis patients (CL) and healthy subjects (HS).
*Po0.05, **Po0.005, ***Po0.001.
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can be activated by cytokines released after the stimulation of
specific cells by Leishmania antigens (Unutmaz et al., 1994).
The finding of T lymphocytes specific to other antigens
within leishmanial lesions was predictable, because the
inflammatory reaction induces a change in the expression
of endothelial adhesion molecules and the release of
chemoattractive cytokines, both of which facilitate the influx
of circulating cells with different specificities to the inflamed
tissue (Tapia et al., 1994; Santamaria Babi et al., 1995;
Butcher and Picker 1996; Ritter et al., 1996; Mendes-Aguiar
et al., 2009). However, the low frequency of T. cruzi–reactive
cells in lesions compared with blood is unexpected and
suggests the selective direction of circulating T. cruzi–specific
lymphocytes into the inflammatory site (Menssen et al., 1995;
Butcher and Picker, 1996).
The demonstration of nonspecific cells also reopens
the question of how these lymphocytes participate in the
immunopathogenesis of leishmaniasis. In an experimental
L. major infection model, irrelevant ovalbumin-specific T cells
enhanced the progression of lesions when the mice were
injected with the parasite in addition to ovalbumin (Titus et al.,
1984). Moreover, it is known that associated diseases can
influence the outcome of leishmaniasis (Santiago et al., 1999;
Da-Cruz et al., 2000; O’Neal et al., 2007). It has been shown
that non–antigen-specific mononuclear cells lead to tissue
damage in hepatitis (Sitia et al., 2004) and autoimmune
encephalomyelitis (Gijbels et al., 1994). These data suggest that
recruitment of lymphocytes specific for other antigens is a
critical step in the generation of the inflammatory infiltrate,
thereby influencing the outcome of the disease.
Taken together, our results show that T cells from
leishmaniasis lesions are able to proliferate and produce
IFN-g, not only in response to leishmanial antigens but
also after stimulation with antigens from other nonrelated
parasites. Therefore, cell populations specific for other
antigens can also migrate to the leishmanial lesion. Modula-
tion of chemokine production by parasite antigens can
certainly contribute to the differential migration of cell
populations. Finally, we hypothesize that although the initial
stimulus is induced by Leishmania antigens, once tissue
injury is established, maintenance of the inflammatory
process is not only a consequence of the specific immune
response. As demonstrated in other diseases, nonspecific T
cells can effectively contribute to the pathological process,
either by producing cytokines or by inducing regulatory
mechanisms. Therefore, elucidating the role of lymphocytes
specific for Leishmania or nonrelevant antigens during
recovery from or aggravation of leishmaniasis is important
in understanding the pathogenesis of the disease.
MATERIALS AND METHODS
Patients
Twenty-four CL patients (16 men and 8 women; mean age
31.2±17.1 years, median 26.5 years) were studied. The diagnostic
criteria were based on clinical, parasitological, histological, and
immunological parameters. The mean duration of the illness before
diagnosis was 83.3±42.9 days (median 67.5 days). Parasites were
isolated from 20 of the 24 cases and were determined to be Lb
(Cupolillo et al., 2003). Leishmania-specific antibodies were
detected by indirect immunofluorescence in 9 of 24 patients. To
investigate a history of toxoplasmosis, we assessed the presence of
Toxoplasma-specific antibodies in the serum using an indirect
immunofluorescence assay. Blood samples from seven healthy
subjects were used as controls.
This study was conducted according to the Declaration of
Helsinki Principles and was approved by the ethics committee of the
Fundac¸a˜o Oswaldo Cruz, Ministe´rio da Sau´de, Brazil. Participants
gave their written informed consent.
Mononuclear cells from leishmanial lesions
Skin biopsies were taken for diagnostic purposes, and mononuclear
cells were obtained from the lesions (Modlin et al., 1986; Da-Cruz
et al., 2005). In brief, the tissue was cut into pieces and pushed
through a 64-mm mesh filter using surgical scalpels. The single-cell
suspension was washed, pelleted by centrifugation, and resuspended
in conical tubes. After decanting for 5minutes, the supernatant,
which was free of debris, was centrifuged over a Ficoll-Hypaque
gradient (Histopaque 1077; Sigma Chemical Co., St Louis, MO). The
ring containing the mononuclear cells was collected and adjusted to
106 cells per milliliter in complete RPMI 1640 supplemented with
10% human AB Rhþ serum.
Lymphocyte proliferative assays
PBMCs were obtained by centrifugation over a Ficoll-Hypaque
gradient (Da-Cruz et al., 1994). LMNCs (105 cells) were cocultured
with 2 105 irradiated (5,000 Grays; Theratron 780; AEC, Gaithersburg,
MD) autologous PBMCs as ‘‘feeder cells.’’ The LMNCs and
PBMCs (3 105 per well) were seeded in triplicate into 96-well,
round-bottom plates (Nunc A/S, Roskilde, Denmark) in a final
volume of 200 ml. ‘‘Feeder cells’’ were also cultured alone as a
control. The cells were incubated for 4 days at 37 1C in a humidified
atmosphere of 5% CO2 in air in the presence of (i) the equivalent of
106 disrupted promastigotes of Lb (MHOM/BR75/M2903) per well,
(ii) 2 106 taquizoites of Tg, (iii) 2 106 epimastigotes of T. cruzi,
(iv) 4mg per well of concanavalin A (Sigma), or (v) medium alone.
After 4 days of culture, 1mCi of 3H-labeled thymidine (Amersham
International, Amersham, UK) was added to each well, and the
cultures were incubated for an additional 16 hours (Da-Cruz et al.,
1994). The results are expressed as counts per minute or as
stimulation indexes, the mean count in the wells containing antigens
or mitogen divided by the background (mean count in nonstimulated
wells). Stimulation indexes equal to or greater than 2.5 were
considered positive. In addition, the supernatants of these cultures
were collected and stored at 20 1C until use. Timed kinetic
experiments had been performed previously to establish the period
of maximum proliferation of cells and the peak of cytokine production.
Flow cytometric analysis of tissue-derived T cells
Leishmanial antigen-reactive T cells were obtained after in vitro
stimulation of LMNCs (106 per well) cocultured with ‘‘feeder cells’’
(2 106 per well). The cells were plated in 24-well, flat-bottom
plates (Nunc, Roskilde, Denmark) and cultured in the presence of
5 106 disrupted Lb promastigotes (2ml per well) under the
conditions described above. After 4 days in culture, the Lb-specific
cells were separated by centrifugation over a discontinuous Percoll
gradient (Sigma). Ex vivo LMNCs as well as Lb-specific blast cells
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were stained with 5ml of monoclonal antibodies: anti-CD3, anti-
CD4, anti-CD8, anti-CD25, anti-CD69, and anti-C1.7/CD244
(Beckman Coulter, Hialeah, FL). For flow cytometric analysis,
10,000 events per sample were acquired using an EPICS ALTRA
flow cytometer (Beckman Coulter), and the data were analyzed
using EXPO32 software (Beckman Coulter).
Limiting dilution assays for analysis of the frequency of
Leishmania- or Toxoplasma-specific T cells
The quantification of the frequency of Lb-specific T cells from blood
and lesions was performed (Conceic¸a˜o-Silva et al., 1990), with some
modifications. Briefly, 32 wells of LMNCs were cultured at four
concentrations (5, 10, 50, or 100 viable cells per well) using 96-well
round-bottom plates in the presence of 2 105 ‘‘feeder cells’’ and
5 105 Lb promastigotes per well. The same procedures were used
for the analysis of Tg-reactive T cells. As a control, 48 wells
containing 2 105 ‘‘feeder cells’’ per well along with the parasite
antigens, as well as 24 replicate wells containing 10 responder cells
and 105 ‘‘feeder-cells’’ without exogenous antigens, were used.
For analysis of the frequency of parasite antigen-reactive
lymphocytes from the blood, 32 wells of PBMCs were cultured at
three concentrations (1 104, 4 104, and 8 104 cells per well) in
200ml per well for 7 days in the presence of Leishmania or
Toxoplasma antigens as described above. The estimate of the
minimal T-cell frequency was calculated using the w2-test method.
The frequency of parasite-specific T cells was estimated as the
reciprocal of the cell concentration at which the in vitro cultures
were negative. The frequency analysis showed that a single-hit
Poisson model was followed in all experiments. The estimated
frequencies were calculated using ELIDA 1.1 software (Carls
Taswell), and results are expressed as the number of parasite antigen
responder lymphocytes per 106 cells.
Quantification of cytokines
The culture supernatants were collected for quantification of IL-4
(day 3), IL-5 (day 3), and IFN-g (day 4). IFN-g was measured by ELISA
using a human IFN-g-specific antibody for capture (clone NIB4S;
Pharmingen, San Diego, CA) and a biotinylated IFN-g-specific
antibody for detection (clone 4S.B3). The limit of detection was
62.5 pgml1. IL-4 and IL-5 were quantified using commercial
Quantikine kits (R&D Systems, Minneapolis, MN) according to the
manufacturer’s protocol, and the limit of detection was 31.2 and
7.8 pgml1 for IL-4 and IL-5, respectively.
Statistical analysis
A Mann–Whitney U-test or Spearman’s rank correlation was
performed using GraphPad Instat V2.04 software (GraphPad
Software, San Diego, CA).
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